Here are three insights.
1. The 6th U.S. Circuit Court of Appeals overturned the lower-court’s decision, requiring Stryker to face jurisdiction in the U.S.
2. Last year, a U.S. court deemed the bribery case against Stryker and the Brazilian insurer needed to be conducted in Brazil.
3. Abramge accused Stryker of paying bribes and kickbacks to local physicians to use their products.
More articles on devices and implants:
Safe Orthopaedics acquires Qspine’s sales force: 5 insights
Medicrea earns world’s 1st FDA approval for patient-specific cages: 5 things to know
Looking to enter the spine market? See the Xoran, Fiagon partnership
